Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥11.43B | ¥10.32B | ¥9.78B | ¥9.27B | ¥7.82B | ¥5.74B | ¥4.12B | ¥2.79B | ¥1.62B | ¥1.06B | ¥703.6M | ¥468.3M |
| Gross profit | ¥2.59B | ¥2.22B | ¥1.95B | ¥1.95B | ¥1.78B | ¥1.55B | ¥1.04B | ¥622.4M | ¥408.5M | ¥265.7M | ¥188.6M | ¥80.2M |
| Research & development | ¥32.7M | ¥36.3M | ¥38.2M | ¥31.9M | ¥39.3M | ¥40.0M | ¥21.6M | ¥13.9M | ¥7.3M | ¥9.1M | ¥3.6M | ¥1.6M |
| Operating income | −¥55.8M | ¥1.15B | −¥2.21B | ¥713.2M | ¥569.5M | ¥672.9M | ¥479.8M | ¥168.4M | ¥82.2M | −¥42.4M | −¥1.2M | −¥75.7M |
| EBITDAderived | ¥3.40B | ¥4.39B | ¥1.16B | ¥3.83B | ¥3.19B | ¥2.31B | ¥1.62B | ¥909.9M | ¥460.4M | ¥185.0M | ¥144.2M | ¥7.1M |
| Net income | ¥949.6M | ¥3.43B | −¥4.29B | −¥1.27B | −¥1.19B | −¥666.4M | −¥442.1M | −¥430.3M | −¥326.9M | −¥276.4M | −¥98.6M | −¥130.0M |
| Basic EPSper diluted share | CN¥0.59 | CN¥2.27 | -CN¥2.96 | -CN¥1.03 | -CN¥0.90 | -CN¥0.59 | -CN¥0.45 | -CN¥0.43 | -CN¥0.42 | -CN¥1.35 | -CN¥0.99 | -CN¥1.91 |
| Diluted EPSper diluted share | CN¥0.55 | CN¥2.27 | -CN¥2.96 | -CN¥1.03 | -CN¥0.90 | -CN¥0.59 | -CN¥0.45 | -CN¥0.43 | -CN¥0.42 | -CN¥1.35 | -CN¥0.99 | -CN¥1.91 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 10, 2026Form 4 | Qian YixinExecutive VP, operation | SellAmerican Depositary Shares | 10.0K | $35.25 | $352.5K | 66.9K |
| Jun 2, 2026Form 4 | Ye Judy QingDirector | SellAmerican Depositary Shares | 37.4K | $36.21 | $1.35M | 0 |